Publication & Citation Trends
Publications
0 total
SGLT2 inhibitor upregulates myocardial genes for oxidative phosphorylation and fatty acid metabolism in Gαq-mice OA
Cited by 4
Semantic Scholar
SGLT2 inhibitor ertugliflozin decreases elevated intracellular sodium, and improves energetics and contractile function in diabetic cardiomyopathy OA
Cited by 18
Semantic Scholar
A soft robotic sleeve mimicking the haemodynamics and biomechanics of left ventricular pressure overload and aortic stenosis OA
Cited by 34
Semantic Scholar
Effects of Sodium‐Glucose Linked Transporter 2 Inhibition With Ertugliflozin on Mitochondrial Function, Energetics, and Metabolic Gene Expression in the Presence and Absence of Diabetes Mellitus in Mice OA
Cited by 55
Semantic Scholar
Recapitulating aortic valve disease hemodynamics with a highly tunable bio-inspired soft robotic aortic sleeve OA
Cited by 1
Semantic Scholar
Redox-Resistant SERCA [Sarco(endo)plasmic Reticulum Calcium ATPase] Attenuates Oxidant-Stimulated Mitochondrial Calcium and Apoptosis in Cardiac Myocytes and Pressure Overload–Induced Myocardial Failure in Mice OA
Cited by 38
Semantic Scholar
Abstract 15315: SGLT2 Inhibitor Ertugliflozin Decreases Elevated Intracellular Sodium, Improves Myocardial Energetics and Enhances Function in Metabolic Heart Disease
Cited by 2
Semantic Scholar
Epigenetic Signatures of Human Myocardium and Brown Adipose Tissue Revealed with Simultaneous Positron Emission Tomography and Magnetic Resonance of Class I Histone Deacetylases OA
Cited by 1
Semantic Scholar
Research Topics
Cardiovascular Function and Risk Factors
(13)
Adipose Tissue and Metabolism
(10)
Pancreatic function and diabetes
(6)
Cardiovascular Disease and Adiposity
(6)
Mitochondrial Function and Pathology
(5)
Affiliations
Boston University
Brigham and Women's Hospital
Novartis (Switzerland)
Boston Medical Center
MACOM (United States)